NCT00479336View on ClinicalTrials.gov

A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema

PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Cirrhosis
Interventions
DRUG

OPC-41061 7.5mg

7.5mg, 1 tablet a day

DRUG

OPC-41061 placebo

placebo, 1 tablet a day

DRUG

OPC-41061 15mg

15mg, 1 tablet a day

DRUG

OPC-41601 30mg

30mg, 1 tablet a day

Trial Locations (7)

Unknown

Chubu Region

Chugoku Region

Hokkaido Region

Kanto Region

Kinki Region

Kyusyu Region

Tohoku Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY